메뉴 건너뛰기




Volumn 24, Issue 9, 2002, Pages 593-613

Preclinical pharmacokinetics of statins

Author keywords

HMG CoA reductase inhibitors; Pharmacokinetics; Preclinical studies; Statins

Indexed keywords

ATORVASTATIN; CERIVASTATIN; FLUINDOSTATIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; MEVINOLIN; PITAVASTATIN; PRAVASTATIN; ROSUVASTATIN; SIMVASTATIN; STATIN;

EID: 12244292690     PISSN: 03790355     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review
Times cited : (49)

References (57)
  • 1
    • 0030953045 scopus 로고    scopus 로고
    • Pharmacodynamics and pharmacokinetics of the HMG-CoA reductase inhibitors
    • Lennernäs, H., Fager, G. Pharmacodynamics and pharmacokinetics of the HMG-CoA reductase inhibitors. Clin Pharmacokinet 1997, 32: 403-25.
    • (1997) Clin Pharmacokinet , vol.32 , pp. 403-425
    • Lennernäs, H.1    Fager, G.2
  • 2
    • 0035023185 scopus 로고    scopus 로고
    • Clinical pharmacokinetics of fluvastatin
    • Scripture, C.D., Pieper, J.A. Clinical pharmacokinetics of fluvastatin. Clin Pharmacokinet 2001, 40: 263-81.
    • (2001) Clin Pharmacokinet , vol.40 , pp. 263-281
    • Scripture, C.D.1    Pieper, J.A.2
  • 3
    • 0031664847 scopus 로고    scopus 로고
    • Pharmacokinetic studies on CI-981 (1): Absorption, distribution and excretion in rats following single oral or intravenous administration
    • Nemoto, H., Ebine, H., Ohzone, Y. et al. Pharmacokinetic studies on CI-981 (1): Absorption, distribution and excretion in rats following single oral or intravenous administration. Jpn Pharmacol Ther 1998, 26: 65-77.
    • (1998) Jpn Pharmacol Ther , vol.26 , pp. 65-77
    • Nemoto, H.1    Ebine, H.2    Ohzone, Y.3
  • 5
    • 0033758172 scopus 로고    scopus 로고
    • NK-104: A novel synthetic HMG-CoA reductase inhibitor
    • Kajinami, K., Mabuchi, H., Saito, Y. NK-104: A novel synthetic HMG-CoA reductase inhibitor. Exp Opin Invest Drugs 2000, 9: 2653-61.
    • (2000) Exp Opin Invest Drugs , vol.9 , pp. 2653-2661
    • Kajinami, K.1    Mabuchi, H.2    Saito, Y.3
  • 6
    • 0033831429 scopus 로고    scopus 로고
    • Clinical pharmacokinetics of cerivastatin
    • Mück, W. Clinical pharmacokinetics of cerivastatin. Clin Pharmacokinet 2000, 39: 99-116.
    • (2000) Clin Pharmacokinet , vol.39 , pp. 99-116
    • Mück, W.1
  • 9
    • 0034495168 scopus 로고    scopus 로고
    • Clinical pharmacokinetics of pravastatin. Mechanisms of pharmacokinetic events
    • Hatanaka, T. Clinical pharmacokinetics of pravastatin. Mechanisms of pharmacokinetic events. Clin Pharmacokinet 2000, 39: 397-412.
    • (2000) Clin Pharmacokinet , vol.39 , pp. 397-412
    • Hatanaka, T.1
  • 10
    • 12244297486 scopus 로고    scopus 로고
    • Merck
    • Whitehouse Station, NJ, USA. September
    • Merck. Zocor® package insert (simvastatin). Whitehouse Station, NJ, USA. September 2000.
    • (2000) Zocor® Package Insert (Simvastatin)
  • 14
    • 0035825928 scopus 로고    scopus 로고
    • Preclinical and clinical pharmacology of rosuvastatin, a new 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor (1)
    • McTaggart, F., Buckett, L., Davidson, R. et al. Preclinical and clinical pharmacology of rosuvastatin, a new 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor (1). Am J Cardiol 2001, 87 (Suppl 1): 28-32.
    • (2001) Am J Cardiol , vol.87 , Issue.SUPPL. 1 , pp. 28-32
    • McTaggart, F.1    Buckett, L.2    Davidson, R.3
  • 15
    • 0026814425 scopus 로고
    • Comparative pharmacokinetics of lovastatin, simvastatin and pravastatin in humans
    • Pentikainen, P.J., Saraheimo, M., Schwartz, J.I. et al. Comparative pharmacokinetics of lovastatin, simvastatin and pravastatin in humans. J Clin Pharmacol 1992, 32: 136-40.
    • (1992) J Clin Pharmacol , vol.32 , pp. 136-140
    • Pentikainen, P.J.1    Saraheimo, M.2    Schwartz, J.I.3
  • 16
    • 0025076205 scopus 로고
    • Disposition of fluvastatin, and inhibitor of HMG-CoA reductase, in mouse, rat, dog, and monkey
    • Tse, F.L.S., Smith, H.T., Ballard, F.H., Nicoletti, J. Disposition of fluvastatin, and inhibitor of HMG-CoA reductase, in mouse, rat, dog, and monkey. Biopharm Drug Dispos 1990, 11: 519-31.
    • (1990) Biopharm Drug Dispos , vol.11 , pp. 519-531
    • Tse, F.L.S.1    Smith, H.T.2    Ballard, F.H.3    Nicoletti, J.4
  • 17
    • 0027378356 scopus 로고
    • Biotransformation of lovastatin. V. Species differences in in vivo metabolite profiles of mouse, rat, dog, and human
    • Halpin, R.A., Ulm, E.H., Till, A.E. et al. Biotransformation of lovastatin. V. Species differences in in vivo metabolite profiles of mouse, rat, dog, and human. Drug Metab Dispos 1993, 21: 1003-11.
    • (1993) Drug Metab Dispos , vol.21 , pp. 1003-1011
    • Halpin, R.A.1    Ulm, E.H.2    Till, A.E.3
  • 18
    • 0029853471 scopus 로고    scopus 로고
    • Cerivastatin, a new inhibitor of HMG-CoA reductase-pharmacokinetics in rats and dogs
    • Steinke, W., Yamashita, S., Tabei, M. et al. Cerivastatin, a new inhibitor of HMG-CoA reductase-pharmacokinetics in rats and dogs. Jpn Pharmacol Ther 1996, 24 (Suppl): 7-27.
    • (1996) Jpn Pharmacol Ther , vol.24 , Issue.SUPPL. , pp. 7-27
    • Steinke, W.1    Yamashita, S.2    Tabei, M.3
  • 20
    • 0026668094 scopus 로고
    • Disposition and metabolism of pravastatin sodium in rats, dogs and monkeys
    • Komai, T., Kawai, K., Tokui, T. et al. Disposition and metabolism of pravastatin sodium in rats, dogs and monkeys. Eur J Drug Metab Pharmacokinet 1992, 17: 103-13.
    • (1992) Eur J Drug Metab Pharmacokinet , vol.17 , pp. 103-113
    • Komai, T.1    Kawai, K.2    Tokui, T.3
  • 21
    • 0029846754 scopus 로고    scopus 로고
    • Tissue-selective uptake of pravastatin in rats: Contribution of a specific carrier-mediated uptake system
    • Yamazaki, M., Tokui, T., Ishigam, M., Sugiyama, Y. Tissue-selective uptake of pravastatin in rats: contribution of a specific carrier-mediated uptake system. Biopharm Drug Dispos 1996, 17: 775-89.
    • (1996) Biopharm Drug Dispos , vol.17 , pp. 775-789
    • Yamazaki, M.1    Tokui, T.2    Ishigam, M.3    Sugiyama, Y.4
  • 22
    • 0024513882 scopus 로고
    • The physiological disposition of lovastatin
    • Duggan, D.E., Chen, I.-W., Bayne, W.F. et al. The physiological disposition of lovastatin. Drug Metab Dispos 1989, 17: 166-73.
    • (1989) Drug Metab Dispos , vol.17 , pp. 166-173
    • Duggan, D.E.1    Chen, I.-W.2    Bayne, W.F.3
  • 23
    • 0025240977 scopus 로고
    • Metabolic disposition studies on simvastatin, a cholesterol-lowering prodrug
    • Vickers, S., Duncan, C.A., Chen, I.-W., Rosegay, A., Duggan, D.E. Metabolic disposition studies on simvastatin, a cholesterol-lowering prodrug. Drug Metab Dispos 1990a, 18: 138-45.
    • (1990) Drug Metab Dispos , vol.18 , pp. 138-145
    • Vickers, S.1    Duncan, C.A.2    Chen, I.-W.3    Rosegay, A.4    Duggan, D.E.5
  • 24
    • 0034961288 scopus 로고    scopus 로고
    • Drug interaction between simvastatin and itraconazole in male and female rats
    • Ishigami, M., Kawabata, K., Takasaki, W. et al. Drug interaction between simvastatin and itraconazole in male and female rats. Drug Metab Dispos 2001, 29: 1068-72.
    • (2001) Drug Metab Dispos , vol.29 , pp. 1068-1072
    • Ishigami, M.1    Kawabata, K.2    Takasaki, W.3
  • 26
    • 0032937343 scopus 로고    scopus 로고
    • The 3- hydroxy- 3-methylglutaryl, coenzyme A reductase inhibitor fluvastatin: Effect on human cytochrome P-450 and implications for metabolic drug interactions
    • Fischer, V., Johanson, L., Heitz, F. et al. The 3- hydroxy- 3-methylglutaryl, coenzyme A reductase inhibitor fluvastatin: Effect on human cytochrome P-450 and implications for metabolic drug interactions. Drug Metab Dispos 1999, 27: 410-6.
    • (1999) Drug Metab Dispos , vol.27 , pp. 410-416
    • Fischer, V.1    Johanson, L.2    Heitz, F.3
  • 27
    • 0032970752 scopus 로고    scopus 로고
    • Simultaneous determination of NK-104 and its lactone in biological samples by column-switching high-performance liquid chromatography with ultraviolet detection
    • Kojima, J., Fujino, H., Yosimura, M., Morikawa, H., Kimata, H. Simultaneous determination of NK-104 and its lactone in biological samples by column-switching high-performance liquid chromatography with ultraviolet detection. J Chromatography 1999, 724: 173-80.
    • (1999) J Chromatography , vol.724 , pp. 173-180
    • Kojima, J.1    Fujino, H.2    Yosimura, M.3    Morikawa, H.4    Kimata, H.5
  • 28
    • 0032962809 scopus 로고    scopus 로고
    • Effect of cerivastatin sodium, a new inhibitor of HMG-CoA reductase, on plasma lipid levels, progression of atherosclerosis, and the lesional composition in the plaques of WHHL rabbits
    • Shiomi, M., Ito, T. Effect of cerivastatin sodium, a new inhibitor of HMG-CoA reductase, on plasma lipid levels, progression of atherosclerosis, and the lesional composition in the plaques of WHHL rabbits. Br J Pharmacol 1999, 126: 961-8.
    • (1999) Br J Pharmacol , vol.126 , pp. 961-968
    • Shiomi, M.1    Ito, T.2
  • 29
    • 0002549759 scopus 로고    scopus 로고
    • Studies on the metabolic fate of NK-104, a new inhibitor of HMG- CoA reductase (4): Interspecies variation in laboratory animals and humans
    • Fujino, H., Kojima, J., Yamada, Y., Kanda, H., Kimata, H. Studies on the metabolic fate of NK-104, a new inhibitor of HMG- CoA reductase (4): Interspecies variation in laboratory animals and humans. Xenobiotic Metab Dispos 1999a, 14: 79-91.
    • (1999) Xenobiotic Metab Dispos , vol.14 , pp. 79-91
    • Fujino, H.1    Kojima, J.2    Yamada, Y.3    Kanda, H.4    Kimata, H.5
  • 30
    • 0026596619 scopus 로고
    • Absorption and disposition of fluvastatin, and inhibitor of HMG-CoA reductase, in the rabbit
    • Tse, F.L.S., Labbadia, D. Absorption and disposition of fluvastatin, and inhibitor of HMG-CoA reductase, in the rabbit. Biopharm Drug Dispos 1992, 13: 285-94.
    • (1992) Biopharm Drug Dispos , vol.13 , pp. 285-294
    • Tse, F.L.S.1    Labbadia, D.2
  • 31
    • 0031845787 scopus 로고    scopus 로고
    • Metabolism and excretion studies in mouse after single and multiple oral doses of the 3 hydroxy-3-methylglutaryl-CoA reductase inhibitor atorvastatin
    • Black, A.E., Sinz, M.W., Hayes, R.N., Woolf, T.F. Metabolism and excretion studies in mouse after single and multiple oral doses of the 3 hydroxy-3-methylglutaryl-CoA reductase inhibitor atorvastatin. Drug Metab Dispos 1998, 26: 755-63.
    • (1998) Drug Metab Dispos , vol.26 , pp. 755-763
    • Black, A.E.1    Sinz, M.W.2    Hayes, R.N.3    Woolf, T.F.4
  • 32
    • 0000332988 scopus 로고    scopus 로고
    • Studies on the metabolic fate of NK-104, a new inhibitor of HMG-CoA reductase (I): Absorption, distribution, metabolism and excretion in rats
    • Kimata, H., Fujino, H., Koide, T., Yamada, Y., Tsunenari, Y., Yanagawa, Y. Studies on the metabolic fate of NK-104, a new inhibitor of HMG-CoA reductase (I): Absorption, distribution, metabolism and excretion in rats. Xenobiotic Metab Dispos 1998, 13: 484-98.
    • (1998) Xenobiotic Metab Dispos , vol.13 , pp. 484-498
    • Kimata, H.1    Fujino, H.2    Koide, T.3    Yamada, Y.4    Tsunenari, Y.5    Yanagawa, Y.6
  • 33
    • 0028242843 scopus 로고
    • High lipophiliicty decreases drug transport across intestinal epithelial cells
    • Wils, P., Warnery, A., Phunga-Ba, V., Legrain, S., Scherman, D. High lipophiliicty decreases drug transport across intestinal epithelial cells. J Pharmacol Exp Ther 1994, 269: 654-8.
    • (1994) J Pharmacol Exp Ther , vol.269 , pp. 654-658
    • Wils, P.1    Warnery, A.2    Phunga-Ba, V.3    Legrain, S.4    Scherman, D.5
  • 34
    • 0026567257 scopus 로고
    • Hepatic and nonhepatic sterol synthesis and tissue distribution following adminis- tration of a liver selective HMG-CoA reductase inhibitor, CI-981. Comparison with selected HMG-CoA reductase inhibitors
    • Bocan, T.M.A., Ferguson, E., McNally, W. et al. Hepatic and nonhepatic sterol synthesis and tissue distribution following adminis- tration of a liver selective HMG-CoA reductase inhibitor, CI-981. Comparison with selected HMG-CoA reductase inhibitors. Biochimica Biophysica Acta 1992, 1123: 133-44.
    • (1992) Biochimica Biophysica Acta , vol.1123 , pp. 133-144
    • Bocan, T.M.A.1    Ferguson, E.2    McNally, W.3
  • 35
    • 0026641368 scopus 로고
    • Tissue selectivity of pravastatin sodium, lovastatin and simvastatin. The relationship between inhibition of de novo sterol synthesis and active drug concentrations in the liver, spleen and testis in rat
    • Koga, T., Fukuda, K., Shimada,Y., Fukami, M., Koike, H., Tsujita, Y. Tissue selectivity of pravastatin sodium, lovastatin and simvastatin. The relationship between inhibition of de novo sterol synthesis and active drug concentrations in the liver, spleen and testis in rat. Eur J Biochem 1992, 209: 315-19.
    • (1992) Eur J Biochem , vol.209 , pp. 315-319
    • Koga, T.1    Fukuda, K.2    Shimada, Y.3    Fukami, M.4    Koike, H.5    Tsujita, Y.6
  • 37
    • 0032456123 scopus 로고    scopus 로고
    • Pharmacokinetic and pharmacodynamic evaluation for tissue-selective inhibition of cholesterol synthesis by pravastatin
    • Hatanaka, T., Honda, S., Sasaki, S., Katayama, K., Koizumi, T. Pharmacokinetic and pharmacodynamic evaluation for tissue-selective inhibition of cholesterol synthesis by pravastatin. J Pharmacokinet Biopharm 1998, 26: 329-47.
    • (1998) J Pharmacokinet Biopharm , vol.26 , pp. 329-347
    • Hatanaka, T.1    Honda, S.2    Sasaki, S.3    Katayama, K.4    Koizumi, T.5
  • 38
    • 0027723663 scopus 로고
    • Terasaki, T Transport mechanism of 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors at the blood-brain barrier
    • Tsuji, A., Saheki, A., Tamai, I., Terasaki, T Transport mechanism of 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors at the blood-brain barrier. J Pharmacol Exp Ther 1993, 267: 1085-90.
    • (1993) J Pharmacol Exp Ther , vol.267 , pp. 1085-1090
    • Tsuji, A.1    Saheki, A.2    Tamai, I.3
  • 39
    • 0000332994 scopus 로고    scopus 로고
    • Studies on the metabolic fate of NK-104, a new inhibitor of HMG-CoA reductase (3): Foeto-placental transfer and mammary excretion after oral administration in rats
    • Fujino, H., Morikawa, S., Kanda, H., Kimata, H. Studies on the metabolic fate of NK-104, a new inhibitor of HMG-CoA reductase (3): Foeto-placental transfer and mammary excretion after oral administration in rats. Xenobiotic Metab Dispos 1998, 13: 508-15.
    • (1998) Xenobiotic Metab Dispos , vol.13 , pp. 508-515
    • Fujino, H.1    Morikawa, S.2    Kanda, H.3    Kimata, H.4
  • 40
    • 0031660328 scopus 로고    scopus 로고
    • Pharmacokinetic studies on CI-981 (2): Absorption, distribution and excretion following repeated oral administration, and placental transfer and transfer to milk and suckling pups following single oral administration
    • Nemoto, H., Takao, A., Noguchi, T. et al. Pharmacokinetic studies on CI-981 (2): Absorption, distribution and excretion following repeated oral administration, and placental transfer and transfer to milk and suckling pups following single oral administration. Jpn Pharmacol Ther 1998, 26: 79-96.
    • (1998) Jpn Pharmacol Ther , vol.26 , pp. 79-96
    • Nemoto, H.1    Takao, A.2    Noguchi, T.3
  • 41
    • 0000626919 scopus 로고    scopus 로고
    • ZD4522 - An HMG-CoA reductase inhibitor free of metabolically mediated drug interactions: Metabolic studies in human in vitro systems
    • McCormick, A.D., McKillop, D., Butters, C.J. et al. ZD4522 - an HMG-CoA reductase inhibitor free of metabolically mediated drug interactions: Metabolic studies in human in vitro systems. J Clin Pharmacol 2000, 40: 1045-65.
    • (2000) J Clin Pharmacol , vol.40 , pp. 1045-1065
    • McCormick, A.D.1    McKillop, D.2    Butters, C.J.3
  • 42
    • 0031843611 scopus 로고    scopus 로고
    • Biotransformation of cerivastatin in mice, rats, and dogs in vivo
    • Boberg, M., Angerbauer, R., Kanhaia, W.K. et al. Biotransformation of cerivastatin in mice, rats, and dogs in vivo. Drug Metab Dispos 1998, 26: 640-52.
    • (1998) Drug Metab Dispos , vol.26 , pp. 640-652
    • Boberg, M.1    Angerbauer, R.2    Kanhaia, W.K.3
  • 43
    • 0028986096 scopus 로고
    • Disposition of [3H] fluvastatin following single oral doses in beagle dogs and rhesus monkeys with bile fistulae
    • Tse, F.L.S., Dain, J.G., Kalafsky, G. Disposition of [3H] fluvastatin following single oral doses in beagle dogs and rhesus monkeys with bile fistulae. Biopharm Drug Dispos 1995, 16: 211-19.
    • (1995) Biopharm Drug Dispos , vol.16 , pp. 211-219
    • Tse, F.L.S.1    Dain, J.G.2    Kalafsky, G.3
  • 46
    • 0001224909 scopus 로고    scopus 로고
    • Studies on the metabolic fate of NK-104, a new inhibitor of HMG-CoA reductase (5): In vitro metabolism and plasma protein binding in animals and human
    • Fujino, H., Yamada, I., Kojima, J., Hirano, M., Matsumoto, H., Yoneda, M. Studies on the metabolic fate of NK-104, a new inhibitor of HMG-CoA reductase (5): In vitro metabolism and plasma protein binding in animals and human. Xenobiotic Metab Dispos 1999, 14: 415-24.
    • (1999) Xenobiotic Metab Dispos , vol.14 , pp. 415-424
    • Fujino, H.1    Yamada, I.2    Kojima, J.3    Hirano, M.4    Matsumoto, H.5    Yoneda, M.6
  • 47
    • 0032914056 scopus 로고    scopus 로고
    • Identification of metabolites of NK-104, an HMG-CoA reductase inhibitor, in rat, rabbit and dog bile
    • Kojima, J., Fujino, H., Abe, H., Yosimura, M., Kanda, H., Kimata, H. Identification of metabolites of NK-104, an HMG-CoA reductase inhibitor, in rat, rabbit and dog bile. Biol Pharm Bull 1999, 22: 142-50.
    • (1999) Biol Pharm Bull , vol.22 , pp. 142-150
    • Kojima, J.1    Fujino, H.2    Abe, H.3    Yosimura, M.4    Kanda, H.5    Kimata, H.6
  • 48
    • 0025316348 scopus 로고
    • In vitro and in vivo biotransformation of simvastatin, an inhibitor of HMG CoA reductase
    • Vickers, S., Duncan, C.A., Vyas, K.P. et al. In vitro and in vivo biotransformation of simvastatin, an inhibitor of HMG CoA reductase. Drug Metab Dispos 1990b, 18: 476-83.
    • (1990) Drug Metab Dispos , vol.18 , pp. 476-483
    • Vickers, S.1    Duncan, C.A.2    Vyas, K.P.3
  • 49
    • 0026316001 scopus 로고
    • Studies on the metabolic inversion of the 6′ chiral center of simvastatin
    • Vickers, S., Duncan, C.A. Studies on the metabolic inversion of the 6′ chiral center of simvastatin. Biochem Biophys Res Comnmn 1991, 181: 1508-15.
    • (1991) Biochem Biophys Res Comnmn , vol.181 , pp. 1508-1515
    • Vickers, S.1    Duncan, C.A.2
  • 51
    • 0025216735 scopus 로고
    • Biotransformation of lovastatin. 1. Structure elucidation of in vitro and in vivo metabolites in the rat and mouse
    • Vyas, K.P., Kari, P.H., Pitzenberger, S.M. et al. Biotransformation of lovastatin. 1. Structure elucidation of in vitro and in vivo metabolites in the rat and mouse. Drug Metab Dispos 1990a, 18: 203-11.
    • (1990) Drug Metab Dispos , vol.18 , pp. 203-211
    • Vyas, K.P.1    Kari, P.H.2    Pitzenberger, S.M.3
  • 52
    • 0025248279 scopus 로고
    • Biotransformation of lovastatin. II. In vitro metabolism by rat and mouse liver microsomes arid involvement of cytochrome P-450 in dehydrogenation of lovastatin
    • Vyas, K.P., Kari, P.H., Prakash, S.R., Duggan, D.E. Biotransformation of lovastatin. II. In vitro metabolism by rat and mouse liver microsomes arid involvement of cytochrome P-450 in dehydrogenation of lovastatin. Drug Metab Dispos 1990, 18: 218-22.
    • (1990) Drug Metab Dispos , vol.18 , pp. 218-222
    • Vyas, K.P.1    Kari, P.H.2    Prakash, S.R.3    Duggan, D.E.4
  • 54
    • 12244287147 scopus 로고
    • Differences in rate of hydrolysis of HMG-CoA reductase inhibitors in human and animal tissues
    • Fukuo, Y., Akaishi, H., Honda, H. et al. Differences in rate of hydrolysis of HMG-CoA reductase inhibitors in human and animal tissues. Atherosclerosis 1994, 109: 254.
    • (1994) Atherosclerosis , vol.109 , pp. 254
    • Fukuo, Y.1    Akaishi, H.2    Honda, H.3
  • 55
    • 0026093336 scopus 로고
    • Metabolism of pravastatin sodium in isolated rat hepatocytes. II. Structure elucidation of the metabolites by n.m.r. spectroscopy
    • Nakamura, T., Yoda, K,., Kuwano, H. et al. Metabolism of pravastatin sodium in isolated rat hepatocytes. II. Structure elucidation of the metabolites by n.m.r. spectroscopy. Xenobiotica 1991, 21: 277-303.
    • (1991) Xenobiotica , vol.21 , pp. 277-303
    • Nakamura, T.1    Yoda, K.2    Kuwano, H.3
  • 56
    • 0026749181 scopus 로고
    • Metabolism of pravastatin sodium in isolated rat hepatocytes. 1. Glutathione conjugate formation reaction
    • Muramatsu, S., Miyaguchi, K., Iwabuchi, H. et al. Metabolism of pravastatin sodium in isolated rat hepatocytes. 1. Glutathione conjugate formation reaction. Xenobiotica 1992, 22: 487-98.
    • (1992) Xenobiotica , vol.22 , pp. 487-498
    • Muramatsu, S.1    Miyaguchi, K.2    Iwabuchi, H.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.